Cheng Ean Chee

3.8k total citations · 1 hit paper
73 papers, 1.9k citations indexed

About

Cheng Ean Chee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Cheng Ean Chee has authored 73 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Cheng Ean Chee's work include Colorectal Cancer Treatments and Studies (14 papers), Cancer Genomics and Diagnostics (12 papers) and Lung Cancer Treatments and Mutations (10 papers). Cheng Ean Chee is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Cancer Genomics and Diagnostics (12 papers) and Lung Cancer Treatments and Mutations (10 papers). Cheng Ean Chee collaborates with scholars based in Singapore, United States and United Kingdom. Cheng Ean Chee's co-authors include Frank A. Sinicrope, Shengbing Huang, Zhineng J. Yang, Gloria Chan, Wei Peng Yong, Morie A. Gertz, David P. Steensma, Ayalew Tefferi, Curtis A. Hanson and Wenting Wu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Cheng Ean Chee

68 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Autophagy in Cancer: Therapeutic Implications

2011 1.0k citations Cheng Ean Chee et al. profile →

Peers

Cheng Ean Chee

EPIDE

ONCOL

PRM

Atsushi Hosui Japan

Yanping Xu China

Vinicio Carloni Italy

Jaclyn LoPiccolo United States

Wei Cui United States

Alexandre Puissant France

Józefa Węsierska‐Gądek Austria

Shengfu Piao United States

Gabriele Zoppoli Italy

Femke Heindryckx Sweden

Atsushi Hosui Japan

Cheng Ean Chee

1.1k ×1.1

721 ×0.9

EPIDE

445 ×1.0

ONCOL

487 ×1.6

99 ×0.5

PRM

Citations per year, relative to Cheng Ean Chee Cheng Ean Chee (= 1×) peers Atsushi Hosui

Countries citing papers authored by Cheng Ean Chee

Since Specialization

Citations

This map shows the geographic impact of Cheng Ean Chee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Ean Chee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Ean Chee more than expected).

Fields of papers citing papers by Cheng Ean Chee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Ean Chee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Ean Chee. The network helps show where Cheng Ean Chee may publish in the future.

Co-authorship network of co-authors of Cheng Ean Chee

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Ean Chee. A scholar is included among the top collaborators of Cheng Ean Chee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Ean Chee. Cheng Ean Chee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blasiak, Agata, Kirthika Senthil Kumar, Chong Boon Teo, et al.. (2025). Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial. npj Precision Oncology. 9(1). 49–49. 4 indexed citations

Pathak, Priyadarshini, Gloria Chan, Dustin A. Deming, & Cheng Ean Chee. (2024). State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation. American Society of Clinical Oncology Educational Book. 44(3). e438466–e438466. 17 indexed citations

Johnson, David, et al.. (2024). Current advances in targeted therapy for metastatic colorectal cancer – Clinical translation and future directions. Cancer Treatment Reviews. 125. 102700–102700. 14 indexed citations

Walsh, Robert J., Matilda Lee, Natalie Y.L. Ngoi, et al.. (2024). Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit. Frontiers in Oncology. 14. 1342346–1342346.

Yong, Wei Peng, Raghav Sundar, Soo Chin Lee, et al.. (2023). Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials. British Journal of Cancer. 128(8). 1514–1520. 2 indexed citations

Cho, Byoung Chul, Chao‐Hua Chiu, Erminia Massarelli, et al.. (2023). Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer. Lung Cancer. 188. 107442–107442. 19 indexed citations

Choo, Joan, Bernadette Reyna Asuncion, Benjamin Kye Jyn Tan, et al.. (2023). Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer. Gastric Cancer. 26(3). 393–404. 12 indexed citations

Fu, Siqing, Gerald S. Falchook, Minal Barve, et al.. (2023). Abstract 2155: Joint modeling of safety and peripheral mode-of-action (MoA) biomarkers to support RP2D identification in Phase 1 study of SAR444245 (SAR’245) as monotherapy (mono) or combined with pembrolizumab (pembro) in patients with advanced solid tumors. Cancer Research. 83(7_Supplement). 2155–2155. 1 indexed citations

Lee, Shing Fung, Balamurugan Vellayappan, Cheng Ean Chee, et al.. (2022). Incident Cardiovascular Diseases Among Survivors of High-Risk Stage II–III Colorectal Cancer: A Cluster-Wide Cohort Study. Journal of the National Comprehensive Cancer Network. 20(10). 1125–1133.e10. 8 indexed citations

10.

Wong, Andrea L.A., Samuel G.W. Ow, Raghav Sundar, et al.. (2022). Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors. Targeted Oncology. 17(2). 141–151. 5 indexed citations

11.

Lim, Joline S.J., Raghav Sundar, Andrew Barnabas Wong, et al.. (2021). 515MO A phase I trial of durvalumab (Durv) in combination with olaparib (Ola) and capivasertib (Cap) in patients (pts) with advanced or metastatic cancers (Ca) (MEDIPAC). Annals of Oncology. 32. S585–S586. 1 indexed citations

12.

Kim, Guowei, Raghav Sundar, Bettina Lieske, et al.. (2020). PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases. Clinical Cancer Research. 27(7). 1875–1881. 37 indexed citations

13.

Chong, Shang Chee, et al.. (2020). Reducing Time to Chemotherapy Administration in the Outpatient Setting of a Tertiary Cancer Centre Using a Design Thinking Approach. Blood. 136(Supplement 1). 18–20.

14.

Conley, Anthony P., George D. Demetri, Robert C. Doebele, et al.. (2020). 539P Patient-reported outcomes (PROs) from patients (Pts) with NTRK fusion-positive (NTRK-fp) solid tumours receiving entrectinib in the global phase II STARTRK-2 study. Annals of Oncology. 31. S471–S472. 2 indexed citations

15.

Chan, Gloria & Cheng Ean Chee. (2019). Making sense of adjuvant chemotherapy in colorectal cancer. Journal of Gastrointestinal Oncology. 10(6). 1183–1192. 65 indexed citations

16.

Kim, Guowei, Jingshan Ho, Yvonne Ang, et al.. (2018). Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis. PubMed. 3(3). 20180118–20180118. 20 indexed citations

17.

Heong, Valerie, Nicholas Syn, Nur Sabrina Sapari, et al.. (2017). Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study. International Journal of Cancer. 142(9). 1890–1900. 9 indexed citations

18.

Chee, Cheng Ean, David P. Steensma, Wenting Wu, Curtis A. Hanson, & Ayalew Tefferi. (2008). Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts. American Journal of Hematology. 83(8). 611–613. 54 indexed citations

19.

Chee, Cheng Ean & Larry M. Baddour. (2007). Legionella maceachernii Soft Tissue Infection. The American Journal of the Medical Sciences. 334(5). 410–413. 12 indexed citations

20.

Bd, Kahan, et al.. (1994). Synergistic effects of cyclosporin analogs--A, D, G, IMM-125--with rapamycin and/or brequinar.. PubMed. 26(5). 3021–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact